title: BluepRINT for moderate-to-low penetrance cancer susceptibility genes needed: breast cancer and beyond.
abstract: RINT1 is a novel moderately penetrant cancer susceptibility gene seen in breast cancer as well as possibly in Lynch syndrome-related cancers.
authors.affiliation: Authors' Affiliations:Division of Medical Oncology, National Cancer Centre; Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore; Genomic Medicine Institute.
authors.forename: Joanne
authors.initials: J
authors.lastname: Ngeow
authors.affiliation: Genomic Medicine Institute, Lerner Research Institute, Taussig Cancer Institute, and Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic; Department of Genetics and Genome Sciences; and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio engc@ccf.org.
authors.forename: Charis
authors.initials: C
authors.lastname: Eng
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000235:genetics*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D018797:Cell Cycle Proteins; C422909:RINT1 protein, human